Details of the Drug
General Information of Drug (ID: DMPGM0V)
| Drug Name |
1-(1-(benzo[b]thiophen-2-yl)cyclohexyl)piperidine
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
BTCP; 112726-66-6; 1-(1-(benzo[b]thiophen-2-yl)cyclohexyl)piperidine; 1-Btcp; GK 13; 1-[1-(1-benzothiophen-2-yl)cyclohexyl]piperidine; 1-(1-Benzo(b)thien-2-ylcyclohexyl)piperidine; N-(1-(2-Benzo(b)thiophenyl)cyclohexyl)piperidine; GK-13; UNII-Q1WR6UP7MW; Q1WR6UP7MW; CHEMBL279556; CHEBI:64145; 1-(1-(2-benzo(b)thienyl)cyclohexyl)piperidine; Piperidine, 1-(1-benzo(b)thien-2-ylcyclohexyl)-; 1-(1-benzo[b]thien-2-ylcyclohexyl)Piperidine; Benocyclidine; C19H25NS; Tocris-0702; Lopac-B-138; Biomol-NT_000007; AC1L3X4G; Lopac0_000226
|
||||||||||||||||||
| Indication |
|
||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||
| #Ro5 Violations (Lipinski): 1 | Molecular Weight (mw) | 299.5 | |||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 5.3 | ||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 2 | ||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 0 | ||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 2 | ||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||
| Drug-Molecule Activity Atlas (DMA)NEW | Click to Jump to the Detailed DMA Information of This Drug | ||||||||||||||||||
| Drug Pharmacogenomic Perturbation (DPP)NEW | Click to Jump to the Detailed DPP Information of This Drug | ||||||||||||||||||
| Drug ADMET Endpoint Profile (DAE)NEW | Click to Jump to the Detailed DAE Information of This Drug | ||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||
Molecular Expression Atlas of This Drug
| The Studied Disease | Discovery agent | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICD Disease Classification | N.A. | |||||||||||||||||
|
||||||||||||||||||
| Molecular Expression Atlas (MEA) | ||||||||||||||||||


